首页> 外国专利> Use of an inhibitor of glucose REABSORCIu00d3N Formula V and a Modulator of proliferator activated receptor (PPAR) selected peroxisomes between rosiglitazone or isagitazona,Useful for treating, preventing or inhibiting the Progress of diseases such as diabetes, Syndrome X, among others; Pharmaceutical composition.

Use of an inhibitor of glucose REABSORCIu00d3N Formula V and a Modulator of proliferator activated receptor (PPAR) selected peroxisomes between rosiglitazone or isagitazona,Useful for treating, preventing or inhibiting the Progress of diseases such as diabetes, Syndrome X, among others; Pharmaceutical composition.

机译:使用罗瑞格列酮或异烟肼之间的过氧化物酶体的式REASORCI葡萄糖V抑制剂和增生激活受体(PPAR)调节剂的用途,可用于治疗,预防或抑制诸如糖尿病,X综合征等疾病的进展;药物组合物。

摘要

Receive Combination Therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of Diabetes and Syndrome X.
机译:接受包含PPAR调节剂和葡萄糖重吸收抑制剂的联合疗法,可用于治疗糖尿病和X综合征。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号